Ariti is pleased to announce its accession to the Your Pharma Partner in Europe (YPP) network, further strengthening its strategic presence in the European pharmaceutical sector and expanding its opportunities for developing new partnerships. Your Pharma Partner in Europe is an alliance of independent pharmaceutical companies established to support pharmaceutical…
LONDON – February [2], 2026 – Ayrmid, Ltd. (“Ayrmid” or the “Company”), the parent company of Gamida Cell Inc., today announced that it has entered into an exclusive distribution agreement with Ariti S.A., a Greece based pharmaceutical company for the distribution of Omisirge (Omidubicel-onlv) in Greece and Cyprus. Under the terms of…
Ariti S.A of Athens, Greece, announced today a strategic partnership with Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases. Through this collaboration, Ariti will spearhead multiple initiatives aiming to raise awareness of rare melanocortin-4 receptor (MC4R) pathway…
Ariti S.A and Insmed Ireland Limited recently signed an agreement for the Greek territory, aiming at increasing awareness of non-tuberculosis mycobacteria pulmonary disease. This agreement marks an important milestone for the pharmaceutical business unit of Ariti as it not only reinforces the current portfolio of its activities but enhances its…
Multiple Sclerosis is a chronic autoimmune disease that affects the central nervous system. 2,300,000 people worldwide are sick of it. A short documentary film for those who appreciate life.sMS – Sharing Multiple Sclerosis